AVNS
Avanos Medical, Inc. News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1,
"returned": 1,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "b25571b5-2565-4f99-becf-803cb876dfc7",
"title": "Avanos Medical Inc (AVNS) Q1 2024 Earnings: Aligns with EPS Projections, Surpasses Revenue Estimates",
"description": "Revenue: Reported $166.1 million, up 4.3% year-over-year, surpassing estimates of $162.90 million.Net Income: From continuing operations was $0.5 million, a si",
"keywords": "GuruFocus, Article, News, GuruFocus Research, AVNS",
"snippet": "Avanos Medical Inc (AVNS, Financial) released its 8-K filing on May 2, 2024, showcasing its financial results for the first quarter of 2024. The company, a prom...",
"url": "https://www.gurufocus.com/news/2425135/avanos-medical-inc-avns-q1-2024-earnings-aligns-with-eps-projections-surpasses-revenue-estimates",
"image_url": "https://static.gurufocus.com/logos/0C0000AR8X.png?5",
"language": "en",
"published_at": "2024-05-02T12:47:05.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "AVNS",
"name": "Avanos Medical, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 127.29783,
"sentiment_score": 0.24175,
"highlights": [
{
"highlight": "<em>Avanos</em> <em>Medical</em> <em>Inc</em> (AVNS, Financial) released its 8-K filing on May 2, 2024, showcasing its financial results for the first quarter of 2024.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Avanos</em> <em>Medical</em>, headquartered in Alpharetta, Georgia, operates primarily in the medical devices and instruments sector, focusing on Digestive Health and Pain Management and Recovery.",
"sentiment": -0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Challenges and Outlook\n\nDespite the positive trends, <em>Avanos</em> <em>Medical</em> faces challenges, including the integration of acquisitions and the ongoing transformation initiatives which could impact short-term operational efficiency.",
"sentiment": 0.3266,
"highlighted_in": "main_text"
},
{
"highlight": "Investor and Market Implications\n\nJoe Woody, CEO of <em>Avanos</em> <em>Medical</em>, expressed satisfaction with the Q1 results, emphasizing the progress towards margin expansion and growth objectives.",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Avanos</em> <em>Medical</em> continues to adapt its strategies to ensure sustainable growth and profitability, aiming to enhance shareholder value in the evolving healthcare landscape.\n\nExplore the complete 8-K earnings release (here) from <em>Avanos</em> <em>Medical</em> <em>Inc</em> for further details.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Avanos</em> <em>Medical</em> <em>Inc</em> (AVNS) Q1 2024 Earnings: Aligns with EPS Projections, Surpasses Revenue Estimates",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "AVNS",
"total_documents": 1,
"sentiment_avg": 0.24175000190734863
}
]
}
Other details
Exchange
- New York Stock Exchange
- equity
- Healthcare
- us